Showing results (961-970 of 1,039) with videos related to

Sort By:
Pageof 104
The Journal of Pediatrics|September 13, 2020
Development of a Risk Model for Pediatric Hospital-Acquired Thrombosis: A Report from the Children's Hospital-Acquired Thrombosis ConsortiumJulie Jaffray, Brian Branchford, Neil Goldenberg, et al.
Nature Protocols|January 13, 2022
IBEX: an iterative immunolabeling and chemical bleaching method for high-content imaging of diverse tissuesAndrea J Radtke, Colin J Chu, Ziv Yaniv, et al.
Journal of Exposure Science & Environmental Epidemiology|April 28, 2019
Pathway analysis of a genome-wide gene by air pollution interaction study in asthmatic childrenDespo Ierodiakonou, Brent A Coull, Antonella Zanobetti, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2012
Therapeutic amprenavir concentrations in cerebrospinal fluidDavid Croteau, Scott Letendre, Brookie M Best, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 2, 2018
Verification of a proteomic biomarker panel to diagnose minor stroke and transient ischaemic attack: phase 1 of SpecTRA, a large scale translational studyAndrew M Penn, Maximilian B Bibok, Viera K Saly, et al.
Translational Stroke Research|January 26, 2018
Differential Proteomics for Distinguishing Ischemic Stroke from Controls: a Pilot Study of the SpecTRA ProjectA M Penn, V Saly, A Trivedi, et al.
Communications Biology|March 23, 2024
A genetic mouse model of lean-NAFLD unveils sexual dimorphism in the liver-heart axisCharlotte Burelle, Valentin Clapatiuc, Sonia Deschênes, et al.
The New Phytologist|April 22, 2026
NPF2 is involved in intracellular pH regulation and ion balance in the diatom Phaeodactylum tricornutumAnna Santin, Monia Teresa Russo, Dany Croteau, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerationsAlfonso Iorio, Andrea N Edginton, Victor Blanchette, et al.
Clinical Pharmacokinetics|August 23, 2019
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc SubgroupPierre Chelle, Cindy H T Yeung, Stacy E Croteau, et al.
Pageof 104